StemGen SpA - Company Review
StemGen SpA - Company ReviewSummary
Stemgen SpA (Stemgen) is a biotech company that conducts research and development of oncological therapies. The company’s research fields include cancer stem cells and neural stem cell studies for the therapy of neurodegenerative diseases, ischemias, spinal cord injuries, gliomas and glioblastomas, ALS, Multiple Sclerosis, Alzheimer’s, and Parkinson’s diseases. It also offers primary tissue banking and analysis, cell culturing, molecular biology, flow cytometry, and advanced mouse models of human brain cancer. Stemgen uses proprietary cell culture technologies for the identification and optimization of novel glioblastoma therapeutics. The company conducts research activities at its laboratory located in the Bicocca campus, University of Milan. Stemgen is headquartered in Milan, Italy.
This comprehensive company report of StemGen SpA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.